-
Durno, C, Ercan, AB, Bianchi, V, Edwards, M, Aronson, M, Galati, M, Atenafu, EG, Abebe-Campino, G, Al-Battashi, A, Alharbi, M, et al.
Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance..
J Clin Oncol
39(25)
:
2779 -2790
2021
view publication
-
Baroni, LV, Sundaresan, L, Heled, A, Coltin, H, Pajtler, KW, Lin, T, Merchant, TE, McLendon, R, Faria, C, Buntine, M, et al.
Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q..
Neuro Oncol
23(8)
:
1360 -1370
2021
view publication
-
Walker, H, Khuong Quang, DA, Campbell, M, Bhatia, K, Williams, M, Sullivan, M, Eisenstat, DD, Kao, K-T, Ng, J, White, M, et al.
Growth hormone and targeted oncological agents: Are we stopping children with brain tumours from reaching their true height potential?.
J Paediatr Child Health
57(8)
:
1170 -1174
2021
view publication
-
Perreault, S, Doz, F, Geoerger, B, Nysom, K, Øra, I, Boni, V, Chisholm, J, DuBois, SG, Gerber, NU, Goto, H, et al.
RARE-07. EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION-POSITIVE PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS.
Neuro-Oncology
23(Supplement_1)
:
i42 -i42
2021
view publication
-
Hansford, J, Huang, J, Dodgshun, A, Li, B, Hwang, E, Leary, S, Gajjar, A, Von Hoff, K, Endersby, R, Wells, O, et al.
EMBR-03. PINEOBLASTOMA: A POOLED OUTCOME STUDY OF NORTH AMERICAN AND AUSTRALIAN THERAPEUTIC DATA.
Neuro-Oncology
23(Supplement_1)
:
i6 -i6
2021
view publication